SEC reporting owner

Laumas Sandeep SEC insider disclosures

Explore Laumas Sandeep's reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001721664
Issuers
5
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

9 METERS BIOPHARMA, INC.0001551986INNT, NMTRYesYes
BioXcel Therapeutics, Inc.0001720893BTAINoYes
Instil Bio, Inc.0001789769TILYesNo
Unicycive Therapeutics, Inc.0001766140UNCYNoYes
Hillstream BioPharma Inc.0001861657HILSNoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

2026-07-292026-05-14UNCYA47,941Not reported
2026-06-162026-05-14UNCYA42,100Not reported
2026-06-162026-05-14UNCYA84,200Not reported
2026-05-192026-05-14UNCYA42,100Not reported
2026-05-192026-05-14UNCYA84,200Not reported
2026-01-132026-01-09BTAIA17,000Not reported
2025-09-132025-09-10TILS12,461Not reported
2025-09-132025-09-10TILS17,539Not reported
2025-07-312025-07-28UNCYA21,200Not reported
2025-04-292025-04-25TILA44,851Not reported

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.